Congratulations to CBR member Dao Qi Zhang, of the Eye Research Institute, for his new award from the National Eye Institute, one of the National Institutes of Health. His grant R01EY022640, Functional Organization of the Retinal Dopaminergic Network, began on January 1, and will last five years, with a total funding of 1.8 million dollars.
The public health relevance of his research is described below.
“Retinal dopamine acts as a neurotransmitter and plays critical roles in modulating retinal circuits, synchronizing the retinal clock, and influencing eye growth. As a result, dopamine deficiency in neurodegenerative diseases such as diabetic retinopathy, retinitis pigmentosa, and Parkinson's disease leads to a number of visual defects involved in spatial and temporal vision, as well as absolute visual sensitivity. The proposed studies will have the potential to yield new insights into the cellular and synaptic mechanisms responsible for pathogenesis of these neurodegenerative diseases, and to suggest novel preventive and therapeutic strategies for them.”
CBR member Dao Qi Zhang, of the Eye Research Institute, is awarded a grant from the National Eye Institute, one of the National Institutes of Health
Created by Brad Roth (roth@oakland.edu) on Sunday, January 5, 2014 Modified by Brad Roth (roth@oakland.edu) on Sunday, January 5, 2014 Article Start Date: Sunday, January 5, 2014
